✦ LIBER ✦

Primary Sjögren's syndrome with severe central nervous system disease

✍ Scribed by Raija K. Niemelä; Markku Hakala

Book ID: 114098647
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 701 KB
Volume: 29
Category: Article
ISSN: 0049-0172
DOI: 10.1016/s0049-0172(99)80033-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunoglobulins within the central nervo

Immunoglobulins within the central nervous system in primary Sjögren's syndrome

✍ Magnus Vrethem; Jan Ernerudh; Folke Lindström; Thomas Skogh 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 801 KB

P152 Vasculitis of central nervous syste

P152 Vasculitis of central nervous system in primary Sjögren's syndrome

✍ R. Gomez-Femandez; M. Rodriguez-Gomez; A. Bravo; A. Willisch; L. Fernandez; J. T 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Central nervous system disease in primar

Central nervous system disease in primary Sjögren’s syndrome: The role of magnetic resonance imaging

✍ Katrin Morgen; Henry F. McFarland; Stanley R. Pillemer 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 232 KB

Evidence of an immunopathogenic basis fo

Evidence of an immunopathogenic basis for central nervous system disease in primary Sjögren's syndrome

✍ Elaine L. Alexander; Jane E. Lijewski; Myles S. Jerdan; Garrett E. Alexander 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 927 KB

Serum complement activation in central n

Serum complement activation in central nervous system disease in sjögren's syndrome

✍ Elaine L. Alexander; Thomas T. Provost; Martin E. Sanders; Michael M. Frank; Kei 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 742 KB

Dystonia; A central nervous system prese

Dystonia; A central nervous system presentation of Sjögren's syndrome

✍ J. S. P. van den Berg; M. W. I. M. Horstink; F. H. J. van den Hoogen; W. J. G. O 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 836 KB

Subcutaneous infusion of apomorphine for 12 hours per day is an effective means of controlling on-off fluctuations and dyskinesias in patients with advanced Parkinson's disease (PD) resistant to other treatment. 1,2 However, this technique requires reinsertion of the injection needle into the skin o